Dr Jose-Carlos Gutiérrez- Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public marketsHe brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugsThe appointment strengthens the company's commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics' mission of changing the future of healthcareOXFORD, England, Jan. 9, 2025 /PRNewswire/ -- Genomics , a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramos to its Board. The appointment will support the company's rapid growth and strengthen its commercial offering globally, with a focus on scaling its life sciences business. The announcement coincides with significant Genomics presence at the J.P

Bupa Health Services has acquired The Dermatology Partnership (TDP) from August Equity to enhance its direct-to-consumer offerings. The financial details of the deal were not disclosed. This acquisition aims to reduce long waiting times for dermatology services in the UK, benefiting Bupa's UK Insurance customers.